-
平臺編號：bio-48919
-
國際編號：ATCC 205027
-
拉丁屬名： Tetrahymena nanneyi
-
規(guī)格：test tube
-
用途：ATCC原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
Tetrahymena nanneyi
ATCC? Number:205027?
Organism: Tetrahymena nanneyi Simon et al.
Designations: 1-23
Isolation: F1 from LB 2 x XQ 5, 1983
Depositors: DL Nanney, EM Simon
Biosafety Level:1
Shipped: test tube
Growth Conditions: ATCCmedium 1034: Modified PYNFH medium (Available from ATCCas ATCCcat. no. 327-X)Max Temperature: 27.0°C Min Temperature: 15.0°C Duration: axenic
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments: II
Classification: KINGDOM: Protozoa
References: 38710: Meyer EB, Nanney DLIsozymes in the ciliated protozoan TetrahymenaIn: Meyer EB, Nanney DLIsozymes: Current topics in biological and medical research13New YorkAlan R. Liss Inc.61-101, 1987
Organism: Tetrahymena nanneyi Simon et al.
Designations: 1-23
Isolation: F1 from LB 2 x XQ 5, 1983
Depositors: DL Nanney, EM Simon
Biosafety Level:1
Shipped: test tube
Growth Conditions: ATCCmedium 1034: Modified PYNFH medium (Available from ATCCas ATCCcat. no. 327-X)Max Temperature: 27.0°C Min Temperature: 15.0°C Duration: axenic
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments: II
Classification: KINGDOM: Protozoa
References: 38710: Meyer EB, Nanney DLIsozymes in the ciliated protozoan TetrahymenaIn: Meyer EB, Nanney DLIsozymes: Current topics in biological and medical research13New YorkAlan R. Liss Inc.61-101, 1987
